{"transactions":[{"id":2339267,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-10T20:39:12.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":39894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date."}],"balance_after":39894,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39894},"source":{"system":"sec-edgar","filing":"0001415889-22-002864","document":"form4-03102022_050359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000141588922002864/form4-03102022_050359.xml","form_type":"4"}},{"id":2339266,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-10T20:39:12.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":4072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 8, 2021, the Reporting Person was granted 16,288 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 8, 2021, the Reporting Person was granted 16,288 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022."}],"balance_after":12216,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4072},"source":{"system":"sec-edgar","filing":"0001415889-22-002864","document":"form4-03102022_050359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000141588922002864/form4-03102022_050359.xml","form_type":"4"}},{"id":2339265,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-10T20:39:12.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":37788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024."}],"balance_after":37788,"derivative":{"underlying":"Class A Common Stock","underlying_shares":37788},"source":{"system":"sec-edgar","filing":"0001415889-22-002864","document":"form4-03102022_050359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000141588922002864/form4-03102022_050359.xml","form_type":"4"}},{"id":2339264,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-10T20:39:12.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":138770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026."}],"balance_after":138770,"derivative":{"exercise_price":5.08,"expiration_date":"2032-03-08","underlying":"Class A Common Stock","underlying_shares":138770},"source":{"system":"sec-edgar","filing":"0001415889-22-002864","document":"form4-03102022_050359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000141588922002864/form4-03102022_050359.xml","form_type":"4"}},{"id":2339263,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2022-03-10T20:39:12.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":4072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,552 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan."}],"balance_after":31775,"source":{"system":"sec-edgar","filing":"0001415889-22-002864","document":"form4-03102022_050359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000141588922002864/form4-03102022_050359.xml","form_type":"4"}},{"id":2718033,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2021-05-11T16:40:47.000Z","date":"2021-05-07","kind":"purchase","acquired":true,"shares":1367,"price":12.28,"value":16786.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":23151,"source":{"system":"sec-edgar","filing":"0001104659-21-064573","document":"tm2115948-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465921064573/tm2115948-1_4seq1.xml","form_type":"4"}},{"id":2718032,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2021-05-11T16:40:47.000Z","date":"2021-05-07","kind":"purchase","acquired":true,"shares":7198,"price":11.65,"value":83856.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.20 to $12.18. The reporting person undertakes to provide Aziyo Biologics, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":21784,"source":{"system":"sec-edgar","filing":"0001104659-21-064573","document":"tm2115948-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465921064573/tm2115948-1_4seq1.xml","form_type":"4"}},{"id":2796198,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"RESTRICTED STOCK UNITS","published_at":"2021-03-10T16:20:24.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":16288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date."}],"balance_after":16288,"derivative":{"underlying":"CLASS A COMMON STOCK","underlying_shares":16288},"source":{"system":"sec-edgar","filing":"0001104659-21-034467","document":"tm219212-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465921034467/tm219212-5_4seq1.xml","form_type":"4"}},{"id":2796197,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2021-03-10T16:20:24.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":97725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025."}],"balance_after":97725,"derivative":{"exercise_price":14.53,"expiration_date":"2031-03-08","underlying":"CLASS A COMMON STOCK","underlying_shares":97725},"source":{"system":"sec-edgar","filing":"0001104659-21-034467","document":"tm219212-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465921034467/tm219212-5_4seq1.xml","form_type":"4"}},{"id":3007833,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-13T21:57:26.000Z","date":"2020-10-13","kind":"exercise","acquired":false,"shares":111788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering.  In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering.  In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering.  In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering)."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":14586},"source":{"system":"sec-edgar","filing":"0001104659-20-114635","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465920114635/a4.xml","form_type":"4"}},{"id":3007832,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2020-10-13T21:57:26.000Z","date":"2020-10-13","kind":"exercise","acquired":true,"shares":14586,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14586,"source":{"system":"sec-edgar","filing":"0001104659-20-114635","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465920114635/a4.xml","form_type":"4"}},{"id":3009800,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-10-08T20:27:31.000Z","date":"2020-10-07","kind":"grant","acquired":true,"shares":100425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date."}],"balance_after":100425,"derivative":{"underlying":"Class A Common Stock","underlying_shares":100425},"source":{"system":"sec-edgar","filing":"0001104659-20-113579","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465920113579/a4.xml","form_type":"4"}},{"id":3009799,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-08T20:27:31.000Z","date":"2020-10-07","kind":"grant","acquired":true,"shares":181783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020."}],"balance_after":181783,"derivative":{"exercise_price":17,"expiration_date":"2030-10-06","underlying":"Class A Common Stock","underlying_shares":181783},"source":{"system":"sec-edgar","filing":"0001104659-20-113579","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644078/000110465920113579/a4.xml","form_type":"4"}},{"id":3969072,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2018-04-04T22:08:42.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":113521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in four equal annual installments beginning April 2, 2019."}],"balance_after":113521,"derivative":{"exercise_price":13.8,"exercise_date":"2019-04-02","expiration_date":"2028-04-02","underlying":"Ordinary Shares","underlying_shares":113521},"source":{"system":"sec-edgar","filing":"0000950138-18-000311","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000311/edgar.xml","form_type":"4"}},{"id":3969071,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Ordinary Shares","published_at":"2018-04-04T22:08:42.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":21740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning April 2, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 563 shares acquired on March 31, 2018 under the Mallinckrodt employee stock purchase plan."}],"balance_after":38957,"source":{"system":"sec-edgar","filing":"0000950138-18-000311","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000311/edgar.xml","form_type":"4"}},{"id":4105045,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:30:50.000Z","date":"2018-01-04","kind":"tax_withholding","acquired":false,"shares":299,"price":23.4,"value":6996.6,"ownership":{"direct":true},"balance_after":16654,"source":{"system":"sec-edgar","filing":"0000950138-18-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000045/edgar.xml","form_type":"4"}},{"id":4105044,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:30:50.000Z","date":"2018-01-03","kind":"tax_withholding","acquired":false,"shares":1068,"price":23.51,"value":25108.68,"ownership":{"direct":true},"balance_after":16953,"source":{"system":"sec-edgar","filing":"0000950138-18-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000045/edgar.xml","form_type":"4"}},{"id":4105043,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:30:50.000Z","date":"2017-01-04","kind":"tax_withholding","acquired":false,"shares":293,"price":53.19,"value":15584.67,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 347 shares acquired between June 30, 2017 and December 31, 2017 under the Mallinckrodt employee stock purchase plan."}],"balance_after":18021,"source":{"system":"sec-edgar","filing":"0000950138-18-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000045/edgar.xml","form_type":"4"}},{"id":4285047,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Ordinary Shares","published_at":"2017-06-12T20:19:30.000Z","date":"2017-06-09","kind":"purchase","acquired":true,"shares":5000,"price":41.264,"value":206320.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 324 shares acquired between December 31, 2016 and March 31, 2017 under the Mallinckrodt employee stock purchase plan."}],"balance_after":17967,"source":{"system":"sec-edgar","filing":"0000950138-17-000478","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000478/edgar.xml","form_type":"4"}},{"id":4501497,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2017-01-05T02:05:02.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":33260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in their entirety on January 3, 2021."}],"balance_after":33260,"derivative":{"exercise_price":51.73,"exercise_date":"2021-01-03","expiration_date":"2027-01-03","underlying":"Ordinary Shares","underlying_shares":33260},"source":{"system":"sec-edgar","filing":"0000950138-17-000020","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000020/edgar.xml","form_type":"4"}},{"id":4501496,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2017-01-05T02:05:02.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":47525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in four equal annual installments beginning January 3, 2018."}],"balance_after":47525,"derivative":{"exercise_price":51.73,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Ordinary Shares","underlying_shares":47525},"source":{"system":"sec-edgar","filing":"0000950138-17-000020","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000020/edgar.xml","form_type":"4"}},{"id":4501495,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Ordinary Shares","published_at":"2017-01-05T02:05:02.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest in three equal annual installments beginning January 3, 2018."}],"balance_after":12643,"source":{"system":"sec-edgar","filing":"0000950138-17-000020","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000020/edgar.xml","form_type":"4"}},{"id":4501494,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":129237,"kind":"person","name":"LLOYD RONALD K.","position":1,"cik":"0001644078","reported_name":"LLOYD RONALD K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & Pres, Hospital"}}],"security":"Ordinary Shares","published_at":"2017-01-05T02:05:02.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":8460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning January 3, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 303 shares acquired between April 6, 2016 and September 30, 2016 under the Mallinckrodt employee stock purchase plan."}],"balance_after":11518,"source":{"system":"sec-edgar","filing":"0000950138-17-000020","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000020/edgar.xml","form_type":"4"}}]}